Nancy Lurker - Jun 14, 2021 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
President & CEO, Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/15/2021, 05:04 PM
Next filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +4.5K +4.13% $0.00 114K Jun 14, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Options Exercise $0 -4.5K -100% $0.00* 0 Jun 14, 2021 Common Stock 4.5K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in three annual installments beginning on 14-Jun-2019